Estrogen therapy in gynecological cancer survivors

Climacteric

Volumn 16, Issue 6, 2013, Pages 611-617

  Guidozzi, F ^a  

^a UNIVERSITY OF THE WITWATERSRAND   (South Africa)

Author keywords

Cervical Cancer; Endometrial Cancer; Estrogen Therapy; Gynecological Cancer Survivors; Menopausal Symptoms; Ovarian Cancer; Overall Survival; Recurrence; Vaginal Cancer; Vulval Cancer

Indexed keywords

ESTRADIOL; ESTROGEN; GESTAGEN; PLACEBO;

CANCER SURVIVOR; ENDOMETRIUM CANCER; ENDOMETRIUM SARCOMA; ESTROGEN THERAPY; GRANULOSA CELL TUMOR; GYNECOLOGIC CANCER; HORMONAL THERAPY; HUMAN; OVARY CANCER; PRIORITY JOURNAL; QUALITY OF LIFE; RETROSPECTIVE STUDY; REVIEW; UTERINE CERVIX CANCER; VAGINA CANCER; VULVA CANCER;

DISEASE-FREE SURVIVAL; ESTROGEN REPLACEMENT THERAPY; ESTROGENS; FEMALE; GENITAL NEOPLASMS, FEMALE; HUMANS; HYSTERECTOMY; MENOPAUSE, PREMATURE; NEOPLASM RECURRENCE, LOCAL; OVARIECTOMY;

EID: 84887911509     PISSN: 13697137     EISSN: 14730804     Source Type: Journal    
DOI: 10.3109/13697137.2013.806471     Document Type: Review

References (55)

1. Trinh X-B, Peeters F, Tjalma WAA. The thoughts of breast cancer survivors regarding the need for starting hormone therapy. Eur J Obstset Gynecol Rep Biol 2006;124:250-3
2. Hinds L, Price J. M enopause, hormone replacement and gynaecologic cancers. Menopause Int 2010;16:89-93
3. Green D, Sklar C, Boice J, Mulvihill J, Stovall M. O varian failure and reproductive outcomes after childhood cancer treatment: Results from the Childhood Cancer Survivor Study. J Clin Oncol 2009:34:2374-81
4. Sklar C. M aintenance of ovarian function and risk of premature menopause related to cancer treatment. J Natl Cancer Inst Monogr 2005;27:25-7
5. Bath L E, Critchley O D, Chambers S E, Anderson R A, Kelmar JH, Wallace WHB. Ovarian and uterine characteristics after total body irradiation in childhood and adolescence: Response to sex steroid replacement. BJOG 1999;106:1265-72
6. Wallace WH, Thomson AB, Kelsey TW. The radiosensitivity of the human oocyte. Hum Reprod 2003;18:117-21
7. Creasman W. Hormone replacement therapy after cancer. Curr Opin Oncol 2005;17:493-9
8. Committee on Gynecologic Practice: ACOG committee opinion. H ormone replacement therapy in women treated for endometrial cancer: Number 234, May 2000. Int J Gynecol Obstet 2001; 73:283-4
9. Hershlag A, Schuster M. R eturn of fertility after autologous stem cell transplantation. Fertil Steril 2002;77:419-23
10. Gallup D G, Stock R J. A denocarcinoma of the endometrium in women 40 years or younger. Obstet Gynecol 1984;64:417-20
11. DiSaia PJ, Creasman WT, eds. Adenocarcinoma of the uterus. In Clinical Gynaecologic Oncology, 6th edn. Philadelphia: Mosby, 2002 :137-71
12. Creasman WT, Henderson D, Hinshaw W, Clarke-Pearson DL. Estrogen replacement therapy in the patient treated for endometrial cancer. Obstet Gynecol 1986;67:326-30
13. Lee RB, Burke TW, Park RC. Estrogen replacement therapy following treatment for stage 1 endometrial carcinoma. Gynecol Oncol 1990;36:189-91
14. Bryant C W. A dministration of estrogens to patients with a previous diagnosis of endometrial adenocarcinoma. South Med J 1990;83:725-6
15. Baker D D. E strogen replacement therapy in patients with previous endometrial carcinoma. Compre Ther 1990;16:28-35
16. Chapman JA, DiSaia P J, Osann K. Estrogen replacement in surgical stage I and II endometrial cancer survivors. Am J Obstet Gynecol 1996;175:1195-200
17. Suriano KA, Mchale M, Mclaren CE, Kuo-Tung Li, Re A, Disaia PJ. Estrogen replacement therapy in endometrial cancer patients: A matched control study. Obstet Gynecol 2001;97:555-60
18. Barakat RR, Bundy BN, Spirtos NM, Bell J, Manuel RS. Randomised double-blind trial of estrogen replacement therapy versus placebo in stage I or II endometrial cancer: A gynaecologic oncology group study. J Clin Oncol 2006;24:587-92
19. Ayhan A, Taskiran C, Simsek S, Sever A. D oes immediate hormone therapy affect the oncologic outcome in endometrial cancer survivors? Int J Gynaecol Cancer 2006;16:805-8
20. Thanopoulou E, Judson I. Hormonal therapy in gynaecological sarcomas. Exp Rev Anticancer Ther 2012;12:885-94
21. Hinds L, Price J. M enopause, hormone replacement and gynaecological cancers. Menopause Int 2010;16:89-93
22. MacLennan AH. HRT in diffi cult circumstances: Are there any absolute contraindications? Climacteric 2011;14:409-17
23. Chu M C, Mor G, Lim C, Zheng W, Parkash, Schwartz P E. Low grade endometrial stromal sarcoma: Hormonal aspects. Gynecol Oncol 2003;90:170-6
24. Simon J, Nachtigall I, Ulrich L G, Eugster-Hausmann M, Gut R. Endometrial safety of ultra-low-dose estradiol vaginal tablets. Obstet Gynecol 2010;116:876-83
25. Guidozzi F, Ball J. Extensive primary cytoreductive surgery for advanced epithelial cancer. Gynecol Oncol 1994;53:326-30
26. Guidozzi F. Living with ovarian cancer. Gynecol Oncol 1993;50:202-7
27. Eeles RA, Tan S, Wiltshaw E, e t al. Hormone replacement therapy and survival after surgery for ovarian cancer. BMJ 1991;302:259-62
28. Guidozzi F, DaPonte A. E strogen replacement therapy for ovarian carcinoma survivors. A randomized controlled study. Cancer 1999;86:1013-18
29. Bebar S, Ursic-Vrscaj M. Hormone therapy after epithelial cancer. Eur J Gynaecol Oncol 2000;21:192-6
30. Ursic-Vrscaj M. Hormone replacement therapy after invasive ovarian serous cystadencarcinoma treatment: The effect on survival. Menopause 2001;8:1460-5
31. Mascarenhas C, Lambe M, Bellocco R, et al. Use of hormone replacement therapy before and after ovarian cancer diagnosis and ovarian survival. Int J Cancer 2006;119:2907-15
32. International Agency for Research on Cancer, World Health Organization. GLOBCAN 2008. http://globcan.iarc.fr/
33. WHO/ICO Information Centre on Human Papilloma Virus (HPV) and cervical cancer. http://who.int/hpvcentre
34. Denny L. Cervical cancer prevention: New opportunities for primary and secondary prevention in the 21st century. Int J Gynecol Obstet 2012;119:S80-4
35. Parazzini F, Vecchia C, Negri E. Case control study of oestrogen replacement therapy and risk of cervical cancer. BMJ 1997;315:85-8
36. Ferenczy A, Gelfand M M, Franco E, Mansour N. H uman papillomavirus infection in postmenopausal women with and without hormone therapy. Obstet Gynecol 1997;90:7-11
37. Brand A H, Bull C A, Cakir B. Vaginal stenosis in patients treated with radiotherapy for carcinoma of the cervix. Int J Gynecol Cancer 2006;16:288-93
38. Sturdee DW, Panay N, International Menopause Society Writing Group. Recommendations for the management of postmenopausal vaginal atrophy. Climacteric 2010;13:509-22 .
39. Ploch E. Hormonal replacement therapy in patients after cervical cancer treatment. Gynecol Oncol 1987;26:169-77
40. Lacey JV, Brinton LA, Barnes WA. Use of hormone replacement therapy and adenocarcinoma and squamous cell carcinomas of the cervix. Gynecol Oncol 200;77 :149-54
41. MacKie R M, Bray C A. H ormone replacement therapy after surgery for stage 1 or 2 cutaneous melanoma. Br J Cancer 2004;90:770-2
42. Madsen BS, Jensen HL, Van den Brule AJ, Wohlfahrt J, Frisch M. Risk factors for invasive squamous cell carcinoma of the vulva and vagina-population-based case-control study in Denmark. Int J Cancer 2008;122:2827-34
43. Hancke K, Foeldi M, Zahradnik H P, Gitsch G, Gilbert L, Denschlag D. Estrogen replacement therapy after endometrial cancer: A survey of physicians prescribing practice. Climacteric 2010;13:271-7
44. Vavillis D, Chatzigeorgiou K, Goulis D, et al. Hormonal replacement therapy in ovarian cancer survivors: A survey among Greek gynaecologists. Eur J Gynaecol Oncol 2011;32:538-41
45. Vavillis D, Tsolakidis D, Goulis DG, et al. Hormone therapy for postmenopausal endometrial cancer survivors: A survey among Greek obstetricians-gynaecologists. Eur J Gynaecol Oncol 2011;32:81-3
46. Burger CW, van Leeuwen FE, Scheele F, Kenemans P. Hormone replacement therapy in women treated for gynaecological malignancy. Maturitas 1999;32:69-76
47. Lin K, Runowicz CD. The wisdom of hormone replacement therapy in survivors of ovarian and endometrial cancer. Gynecol Oncol 2001;81:987-93
48. Biglia N, Gadduci A, Ponzone R, Roagna R, Sismondi P. H ormone therapy in cancer survivors. Maturitas 2004;48:333-46
49. Michaelson-Cohen R, Beller U. M anaging menopausal symptoms after gynaecological cancer. Curr Opin Oncol 2009;21:407-11
50. Hinds L, Price J. M enopause, hormone replacement and gynaecological cancers. Menopause Int 2010;16:89-93
51. Singh P, Oehler MK. Hormone replacement after gynaecological cancer. Maturitas 2010;65:190-7
52. Ibeanu O, Modesitt SC, Ducie J, von Gruenigen V, Agueh M, Fader AF. Hormone replacement therapy in gynaecologic cancer survivors: Why not? Gynecol Oncol 2011;122:447-54
53. Manley K, Edey K, Braybrooke J, Murdoch J. Hormone replacement therapy after endometrial cancer. Menopause Int 2012;18:134-8
54. Biliatis I, Thomakos N, Rodolakis A, Akrivos N, Zacharakis D, Antsaklis A. Safety of hormone replacement therapy in gynaecological cancer survivors. J Obstet Gynaecol 2012;32:321-5
55. Cairu L, Samsioe G, Iosif C. Q uality of life in endometrial cancer survivors. Maturitas 1999;31:227-36